Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Neyts

Showing results (1-10 of 587) with videos related to

Pageof 59
Sort By:
Antiviral Research|July 18, 2006
Selective inhibitors of hepatitis C virus replicationJohan Neyts
Gastroenterology|May 25, 2024
A Hepatitis E Virus Infection Model in the Mongolian Gerbil: Ready for Antiviral and Vaccine StudiesJérôme Gouttenoire, Johan Neyts
Journal of Hepatology|July 22, 2014
mTOR-inhibitors may aggravate chronic hepatitis EYannick Debing, Johan Neyts
Vaccine|December 28, 2017
The path towards effective antivirals against rabiesDirk Jochmans, Johan Neyts
Cell Host & Microbe|October 14, 2016
Zika and Other Emerging Viruses: Aiming at the Right TargetKai Dallmeier, Johan Neyts
Hepatology (Baltimore, Md.)|June 10, 2023
Toward antivirals against hepatitis E: In the steps of hepatitis CJérôme Gouttenoire, Johan Neyts
European Heart Journal. Acute Cardiovascular Care|May 5, 2020
Medical treatment options for COVID-19Leen Delang, Johan Neyts
Antiviral Research|December 31, 2013
Antiviral strategies for hepatitis E virusYannick Debing, Johan Neyts
Analytical Biochemistry|November 6, 2012
Simple and inexpensive three-step rapid amplification of cDNA 5' ends using 5' phosphorylated primersKai Dallmeier, Johan Neyts
Antiviral Research|March 5, 2003
Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectivesJohan Neyts, Erik De Clercq
Pageof 59

Showing results (1-10 of 587) with videos related to

Sort By:
Pageof 59
Antiviral Research|July 18, 2006
Selective inhibitors of hepatitis C virus replicationJohan Neyts
Gastroenterology|May 25, 2024
A Hepatitis E Virus Infection Model in the Mongolian Gerbil: Ready for Antiviral and Vaccine StudiesJérôme Gouttenoire, Johan Neyts
Journal of Hepatology|July 22, 2014
mTOR-inhibitors may aggravate chronic hepatitis EYannick Debing, Johan Neyts
Vaccine|December 28, 2017
The path towards effective antivirals against rabiesDirk Jochmans, Johan Neyts
Cell Host & Microbe|October 14, 2016
Zika and Other Emerging Viruses: Aiming at the Right TargetKai Dallmeier, Johan Neyts
Hepatology (Baltimore, Md.)|June 10, 2023
Toward antivirals against hepatitis E: In the steps of hepatitis CJérôme Gouttenoire, Johan Neyts
European Heart Journal. Acute Cardiovascular Care|May 5, 2020
Medical treatment options for COVID-19Leen Delang, Johan Neyts
Antiviral Research|December 31, 2013
Antiviral strategies for hepatitis E virusYannick Debing, Johan Neyts
Analytical Biochemistry|November 6, 2012
Simple and inexpensive three-step rapid amplification of cDNA 5' ends using 5' phosphorylated primersKai Dallmeier, Johan Neyts
Antiviral Research|March 5, 2003
Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectivesJohan Neyts, Erik De Clercq
Pageof 59